Updated:
Everbright San Shan Capital Management
Everbright San Shan manages state-linked growth equity in Beijing, targeting industrial and tech sectors aligned with China's five-year plans.
Everbright San Shan Capital Management
Everbright San Shan Capital Management was established as the private equity arm within the China Everbright Limited ecosystem, the Hong Kong-listed investment conglomerate ultimately controlled by the state-owned China Everbright Group. The platform was built to channel domestic institutional capital into later-stage ventures and expansion rounds, a mandate that distinguishes it from Everbright's earlier cross-border fund-of-funds programs. Its Beijing headquarters situates the firm at the nexus of regulatory access and deal origination in northern China's SOE-dominated economy. The firm runs concentrated sector strategies across advanced manufacturing, clean energy, enterprise technology services, and healthcare — segments that map directly onto China's five-year planning cycles. Typical check sizes range from RMB 50 million to RMB 300 million, targeting minority stakes with board representation in companies approaching IPO readiness on the Shanghai STAR Market or Shenzhen ChiNext. Portfolio construction favors structured exits through domestic A-share listings rather than trade sales, reflecting the state-parent's preference for maintaining strategic ownership channels. Geographic exposure concentrates on the Yangtze River Delta and Beijing-Tianjin-Hebei corridors, with selective deployments in Sichuan and Hubei province-linked industrial zones. Team size and fund-level AUM are not publicly disclosed, consistent with onshore RMB fund opacity norms in China's restricted asset management sector. The firm has not announced fund closes or major portfolio exits through international press. Capital is raised principally from provincial government guidance funds, state-owned insurers, and the parent group's balance sheet, placing Everbright San Shan in the center of the state-capital allocation apparatus. Adjacent vehicles within the Everbright ecosystem include cross-border credit funds and a legacy secondaries platform, though operational separation between these entities is not publicly documented. Structurally, the firm's investment committee draws on Everbright Group's banking and securities arms for deal clearance, making underwriting decisions a de facto multi-agency review process. This architecture reduces execution speed but provides a regulatory moat that pure private-sector competitors in China's domestic PE market cannot replicate. Succession and leadership continuity remain tied to central SASAC appointments, a governance model that prioritizes policy alignment over independent fiduciary dynamics.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Sector focus
Frequently asked questions
Is Everbright San Shan a separate entity or a division within China Everbright Group?
It operates as a distinct private equity platform under China Everbright Limited, the Hong Kong-listed investment arm ultimately owned by the state-run China Everbright Group. The parent structure provides balance sheet support and regulatory cover, but the fund management team functions with its own deal sourcing and portfolio mandates focused on onshore RMB-denominated investments.
What types of investors commit capital to Everbright San Shan's funds?
Its limited partner base consists overwhelmingly of domestic Chinese institutional capital: provincial government guidance funds, state-owned banks and insurers, and the parent group's own capital reserves. Foreign institutional participation in their blind-pool vehicles is not publicly recorded, consistent with China's forex controls and restricted QFLP frameworks for onshore funds.
Does Everbright San Shan invest outside of China?
Its primary investment scope is mainland China, with concentration in the Beijing-Tianjin-Hebei and Yangtze River Delta economic zones. The firm does not run an active cross-border direct investment program; overseas exposure, if any, would flow through the broader Everbright ecosystem's separate cross-border credit and secondaries vehicles rather than this onshore PE arm.
How does the firm exit its portfolio positions?
The preferred exit route is a domestic A-share IPO on China's Shanghai STAR Market or Shenzhen ChiNext exchange, reflecting the state-parent's interest in retaining portfolio companies within accessible domestic listings. Trade sales to strategic buyers are less common for core holdings, given the mandate alignment with maintaining strategic ownership channels.
What distinguishes Everbright San Shan from other domestic RMB private equity managers?
Its underwriting process integrates review from the parent group's banking and securities subsidiaries, giving investment committee decisions a quasi-regulatory character that independent RMB fund managers do not face. This creates slower decision velocity but provides policy-risk insulation and preferential access to state-originated deal streams in sectors like advanced manufacturing and energy transition.
Which sectors are formally excluded from Everbright San Shan's investment mandate?
The firm does not publish a formal exclusion list. However, its observable portfolio concentrates on manufacturing, energy, tech, and healthcare — sectors designated as strategic under China's industrial policy. Consumer internet, branded luxury, and purely financial services plays appear absent from disclosed deal activity, consistent with state-capital preferences for asset-heavy or technology-adjacent exposure.
Who approves investment decisions at Everbright San Shan?
The investment committee is not limited to the PE platform's own professionals; it draws on senior personnel from China Everbright Group's banking and securities entities. This makes deal approval a multi-agency process, with ultimate accountability resting with state-appointed leadership whose appointments are governed by China's SASAC system rather than a typical GP partnership model.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: